Table 1.
Patient and tumor characteristics
| Number of patients | 9 |
| Dose level 1 (25 mg sunitinib) | 6 |
| Dose level 2 (37.5 mg sunitinib) | 3 |
| Gender | |
| Female | 3 |
| Male | 6 |
| Age | |
| Median (range), years | 52 (29–75) |
| Tumor site | |
| Retroperitoneum | 4 |
| Lower Extremity | 3 |
| Groin | 1 |
| Chest wall | 1 |
| Tumor size | |
| Median (range), cm | 11 (5–20) |
| Grading (FNLCC) | |
| Low grade | 1 |
| Intermediate grade | 1 |
| High grade | 7 |
| Histology | |
| Dedifferentiated liposarcoma | 4 |
| Undifferentiated pleomorphic sarcoma | 2 |
| Myxoid liposarcoma | 1 |
| Myxofibrosarcoma | 1 |
| Synovial sarcoma | 1 |